Biotech Business Week articles from October 2004

Biotech Business Week archives from October 2004

Study shows ACP-103 improves clinical profile of haloperidol treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Acadia Pharmaceuticals, Inc., (ACAD), a biopharmaceutical company utilizing innovative science to fuel drug discovery and clinical development of novel treatments for central nervous system disorders,...

Graffinity Pharmaceuticals and MyoContract merge.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Privately held Graffinity Pharmaceuticals, AG, and MyoContract, AG, announced that the companies have merged to form Santhera Pharmaceuticals, AG. Santhera Pharmaceuticals will focus on the...

Bariatric surgeons granted U.S. patent for gastric bypass surgical procedure.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- James A. Sapala, MD, and Michael H. Wood, MD, two surgeons at Centers for Obesity Related Illness (CORI), recently received a United States patent publication for Micropouch gastric bypass surgery -...

Company licenses exclusive rights to cinnamylidene-anabaseines compounds.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Critical Therapeutics, Inc., (CRTX), a biopharmaceutical company focused on the discovery, development, and commercialization of products for respiratory, inflammatory, and critical care diseases,...

Company licenses promising cancer detection technology from UMMS.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The University of Massachusetts Medical School (UMMS) and Cytyc Corp. (CYTC) have signed licensing and sponsored-research agreements related to cancer-detection technology developed at UMMS that may...

Interim results reported for phase II study using Tostrelle gel.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., announced positive results of a second interim analysis of a phase II study using its product, Tostrelle (testosterone gel) 0.5%, to treat postmenopausal women with low...

11.5% of Biodyne acquired by technology company.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- QuantumBit Induction Technology Inc. (OTC:QBIT) has acquired 11.5% of Biodyne Inc. Biodyne Inc. is a Houston-based, privately held, biomedical development firm, and has engaged Biodyne in the...

Paper describes new treatment for prevention of postsurgical adhesions.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced that Dr. Johanne Cashman, director of preclinical research, published a paper entitled "Camptothecin-loaded Films for the Prevention of Postsurgical Adhesions" in...

Food Allergy Buddy dining card launched.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Philip Lempert, known by both consumers and the food industry as the "Supermarket Guru" and an expert analyst on consumer, marketing and food safety trends, announced the launch of the Food Allergy...

Colostrinin found to be potential major advance in Alzheimer disease treatment.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- In vivo study in chicks shows that ReGen's Colostrinin reduces memory impairment induced by the toxic protein involved in Alzheimer disease. An in vivo study showing that pretreatment with...

Request submitted to FDA for designated new animal drug listing.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Amarillo Biosciences, Inc., (AMAR) announced that it has submitted requests to the U.S. Food & Drug Administration's (FDA) Office of Minor Use and Minor Species Animal Drug Development (MUMS) for...

Company updates the European development status of micafungin.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Fujisawa Pharmaceutical Co., Ltd., announced that it now expects the approval of its injectable candin antifungal agent micafungin in Europe to be in the first half of 2006 because additional data have...

Hand-held device measures airway inflammation.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Clinical data on a new first-of-a-kind hand-held analyser of inflammation in asthma patients, Niox Mino, were presented for the first time on September 5, 2004, at the European Respiratory Society (ERS)...

Potential asthma monoclonal antibody to enter phase I clinical trial.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CATG) will be starting a phase I clinical trial of CAT-354, a human anti-IL-13 monoclonal antibody, which is a potential treatment for severe asthma, following recent...

Regular sustained combination therapy may reduce asthma exacerbations.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- New data presented at the 14th annual European Respiratory Society (ERS) Congress in Glasgow have revealed the results of the EXCEL (EXacerbation Control Evaluated in a 6 month Long) study, a head to...

Scientists discover link between serotonin and airway allergic inflammation.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Scientists at the La Jolla Institute for Molecular Medicine (LJIMM) have discovered that serotonin, a naturally occurring neurotransmitter that is elevated in the blood of asthmatics, can directly cause...

Baby products manufacturer presented the consumers' choice award.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- On The Go Healthcare, Inc., (OTC Bulletin Board: OGHI) announced that its Compuquest subsidiary was presented the Consumers' Choice Gold Award for business excellence. "We are quite excited and...

Gold award recipient for excellence in design of kidney transport system named.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- ZEVEX International Inc. (ZVXI) announced that it was the recipient of a 2004 Medical Design Excellence Award (MDEA) at the Medical Design and Manufacturing trade show. ZEVEX is a primary designer...

Materials technologies specialist nominated for World Technology Award.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- MIV Therapeutics Inc. (OTCBB) announced that Tom Troczynski, PhD, MIVT vice president of coatings and professor of ceramics at The University of British Columbia, has been selected as a nominee for the...

Backpack safety starting to pay off.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- New numbers show that the Backpack Safety Awareness movement is making a difference for school-age children across the country. According to the United States Consumer Products Safety Commission...

Pharma company announces positive prostate drug trial results.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced new 1-year follow-up results from phase 2 testing of NX-1207, the company's investigational new drug for benign prostatic hyperplasia (BPH). ...

Biophysics institute receives grant for first U.S-based 4Pi Nanoscale Microscope.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The 4Pi Confocal Laser Scanning Microscope is coming to the United States in 2005 through a $732,624 U.S. National Science Foundation grant to a Maine interdisciplinary biophysical research program. ...

Researchers identify a cardiolipin-remodeling enzyme in the mouse.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- "ALCAT1 represents the first identified cardiolipin-remodeling enzyme from any living organism," researchers say. "Cardiolipin is a major membrane polyglycerophospholipid that is required for the...

New York blood center sought donations during national preparedness month.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- New York Blood Center supported the U.S. Department of Homeland Security and other federal agencies and national organizations during the proclaimed National Preparedness Month. "In current times,...

Freestyle Mini, Precision Xceed blood glucose monitors launched in Europe.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories introduced the FreeStyle Mini and Precision Xceed blood glucose monitoring systems for Europe at the 40th Annual Meeting of the European Association for the Study of Diabetes in...

Phase II clinical trial for Hemospan initiated.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Sangart, Inc., announced the initiation of a phase II clinical trial involving Hemospan (MP4), a hemoglobin-based oxygen carrier designed to serve as an alternative for blood transfusions. This...

Study shows clinical efficiency key to success of bone graft substitutes market.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Even as new applications and innovative products create exciting growth opportunities, the key challenge for bone graft substitutes suppliers is to produce material with clinical efficacy equivalent to,...

European marketing authorization issued for expanded use of Gliadel Wafer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals Inc. (GLFD) announced that its proprietary treatment for brain cancer, Gliadel Wafer (polifeprosan 20 with carmustine implant), has been granted extended marketing authorization...

Orphan drug designation granted for Antineoplastons A10 and AS2-1.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Burzynski Research Institute (BRI) (BZYR) announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for its drug candidates Antineoplastons A10 and AS2-1 for the...

Bonefos accepted for filing and granted priority review by FDA.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany (SCH, SHR) announced that Bonefos (clodronate) has been accepted for filing and designated for priority review by the U.S. Food and Drug Administration (FDA). Berlex...

New test discovers breast cancer at early, most treatable stage.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Doctors may soon have a new tool - a noninvasive, painless nipple fluid test - in their fight to make breast cancer a more treatable, nonfatal disease. Within the next couple years, women will be...

U.S. FDA grants review of post-tamoxifen drug for early breast cancer.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Novartis Oncology announced that its supplementary new drug application for Femara (letrozole) has been granted priority review by the U.S. Food and Drug Administration (FDA) for an indication in the...

Biopharmaceutical company receives $1.5 million from exercise of warrants.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- RegeneRx Biopharmaceuticals, Inc., (OTCBB:RGRX) announced that it received $1.5 million from Defiante Farmaceutica, L.d.a., a wholly owned subsidiary of the Italian pharmaceutical group, Sigma-Tau, in...

Consumer products company confirms first quarter guidance.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The Procter & Gamble Company (NYSE:PG) confirmed previously announced earnings guidance for the July - September quarter in line with analysts' current consensus estimate. The current consensus...

Financial results, clinical pipeline update provide by pharma company.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cambridge Antibody Technology (CATG) announced financial results for the 9 months ended June 30, 2004, a business update for the period since the interim results on May 17, 2004, and a clinical pipeline...

Hemaseel maker provides Q3 update.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Haemacure is pursuing the development of its proprietary fibrin sealant (Hemaseel HMN) and thrombin (Hemaseel Thrombin) products and is currently negotiating an agreement for the manufacture of product...

Home infusion therapy company provides 2004 financial results.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Option Care, Inc., (NASDAQ:OPTN) affirmed previously issued guidance for 2004 diluted earnings per share of $0.84 to $0.87. Raj Rai, Option Care's chief executive officer commented, "We continue to...

Monitoring company announces stock repurchase.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- OSI Systems, Inc., (Nasdaq:OSIS) announced that it has recently completed the purchase of 107,500 shares of the company's common stock on the open market at an average purchase price of $14.73 per...

Pharmaceutical company reiterates commitment to Mylan Laboratories transaction.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) reiterated that the company is steadfastly committed to its previously announced combination with Mylan Laboratories Inc. (MYL), as King believes the combination makes...

Pharmaceutical firm reports best year ever for sales, profits.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Aceto Corporation (ACET), a global distributor of chemically derived pharmaceuticals, biopharmaceuticals, specialty chemicals and agrochemicals, announced record results of operations for the fourth...

Venture capital company closes Inaugural fund under management.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Quaker BioVentures announced that it has closed its inaugural fund with approximately $280 million under management. Founded in early 2002 by veterans from the life sciences industry, Quaker is...

Forecast: Generic erosion may stunt growth of bipolar disorder drug market.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., forecasts that generic erosion will significantly stunt the growth of the bipolar disorder drug market in the United States. According to the new Pharmacor study entitled...

2004 Employer and Coalition Service Profiles Supplement released.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Health Industries Research Companies (HIRC) has released its 2004 Employer and Coalition Service Profiles Supplement. The 2004 Profiles Supplement focuses on key demographic and attitudinal data...

Clinical research organization implements quality management initiative.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- PRA International (PRA) announced the global implementation of the PRA Management System (PRAMS), a fully integrated quality management initiative. PRA International is committed to attaining the...

Company announces US$24.4 million in sterols sales agreement.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Forbes Medi-Tech, Inc., (FMTI) announced that it has secured a sterols sales agreement for US$24.4 million over a 3-year period beginning in January 2005. This new customer agreement is between...

Company focuses on regenerative medicine, sells blood conservation technology.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Gary Tureski, president and cofounder of Harvest Technologies Corp., discussed the recent sale of the assets of Harvest's blood conservation technologies to Haemonetics Corp., Braintree, Massachusetts....

ENT-103 maker provides progress report and litigation update.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Entropin, Inc., (ETOP), a development-stage pharmaceutical company focused on the pain-therapy market, provided a progress report on its lead drug candidate, ENT-103, and a litigation update. ...

Electrophysiology company enters relationship with Partners Equity Capital.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD), announced a strategic alliance with Partners Equity Capital Co. (PECC) to provide specialized financing programs to EP MedSystems' customers to facilitate the purchase of...

Enterprise renames itself.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- PhytoMedical Technologies, Inc., (PYTO), has successfully completed its name change from Enterprise Technologies, Inc. The new name more accurately reflects the company's entry into the research,...

Financing for international distribution of Snorenz/SnoreAway announced.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Med Gen Inc. (MDGN) has reached an agreement whereby Med Gen's secured lender would help finance the distribution of Snorenz/SnoreAway and Good Nights Sleep into the international marketplace. Med...

Genomics company expands, relocates to new facility.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Agencourt Bioscience Corporation, a provider of genomic services and nucleic acid purification products to the life sciences industry, celebrated the grand opening of its new corporate headquarters in...

Healthcare REIT closes new $300 million credit facility, declares dividend.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Ventas, Inc. (VTR) said its subsidiary, Ventas Realty, Limited Partnership, closed its new $300 million secured revolving credit facility initially priced at 125 basis points over LIBOR. The new...

ImpactRx selects wireless solution for data collection, transport needs.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Sprint (FON) announced an agreement to provide ImpactRx with a wireless solution for its data collection and transport needs. Through a multiyear agreement, Sprint will provide wireless voice and...

Instrument maker announces new headquarters.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Argonaut Technologies (AGNT), a provider of chemistry instruments and consumables to help the pharmaceutical industry accelerate drug development, announced the relocation of its corporate headquarters...

Licensing agreement announced for hydrodynamic gene delivery technology.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Mirus Bio Corporation has entered into an agreement with Genzyme Corporation covering research applications of Mirus' proprietary hydrodynamic gene delivery technology. Under this agreement,...

Medical device company named to list of 100 fastest-growing companies.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Advanced Neuromodulation Systems, Inc., (ANS, ANSI) was recently ranked 22nd on Fortune magazine's 16th annual list of 100 Fastest-Growing Companies. "ANS is honored to appear on such a prestigious...

Medical-technology company establishes U.S. operations.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- CoreValve, SA, a privately held medical-technology company, announced that it has established U.S. operations in Irvine, California, and has hired a management and product-development team to...

Nonprofit hospitals alliance partners with Sinaiko Healthcare Consulting.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Premier Inc., an alliance of 1,500 non-profit hospitals nationwide, announced that it has signed a partnership agreement in which its Premier Healthcare Informatics group has designated Sinaiko...

Nutritional supplements company reports a 34% increase in customers.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- AMS Health Sciences, Inc., (AMM, AMS) announced August month-end results of its new customer acquisition program, totaling 8751 new associates and preferred customers, averaging $60 per monthly...

Partnership to promote R&D programs, technologies, products in Japan.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Jurilab has established a partnership with Summit Pharmaceuticals International Corporation (SPI) to promote Jurilab's research and development programs, technologies, and products in Japan. Under...

Pharma company unites divisions to become more R&D driven.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Daiichi Pharmaceutical Co., Ltd. will establish an R&D Division, uniting the former Development Division and Research Division, to bolster its competitiveness in terms of global R&D as part of efforts...

PillCam is the new brand name for video capsule product line.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Given Imaging (GIVN), a capsule endoscopy company, announced that it will change the brand name of its line of video capsules from M2A to PillCam effective immediately. PillCam endoscopy is,...

Surgery center owner expands with purchases in Ohio, Indiana and Louisiana.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Symbion, Inc. (SMBI), an owner and operator of surgery centers, announced expansion in Indiana, Louisiana and Ohio through the addition of 3 surgery centers. Terms of the transactions were not...

X-ray technology company announces productivity initiative.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Bruker BioSciences Corporation (BRKR) announced a major productivity initiative with the dual objectives of accelerating the company's drive towards sustained and growing profitability while continuing...

PSA era is over for predicting prostate cancer risk, say Stanford researchers.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The PSA test, commonly used as a screening tool for detecting prostate cancer, is now all but useless for predicting prostate cancer risk, according to Stanford University School of Medicine...

Phase I study of TNFerade for soft tissue sarcoma published.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (NASDAQ:GNVC) announced that results from a phase 1 study for its lead product candidate, TNFerade, in patients with soft tissue sarcoma of the extremities were published in the Clinical...

Gene therapy for bladder cancer shows strong results in animal studies.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Gene therapy that causes the bladder to act like a "bioreactor" to produce and secrete the anticancer agent interferon-alpha has shown dramatic benefits in preclinical tests, say researchers at The...

Pharma company finds anticancer drug effective in reducing tumor size.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Solbec Pharmaceuticals Ltd (ASX:SBP) announced that its anticancer drug SBP002 was effective in reducing tumor size in some patients involved in a phase I trial, and have requested to continue taking...

Radiation therapy center operator announces financing deal.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- OnCURE Medical Corp. (OnCURE) announced that it has completed a $15 million debt financing to fund future acquisitions and restructure its existing line of credit and other debt. Approximately $7...

Radiation therapy management company expands into New Jersey.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Radiation Therapy Services, Inc., (NASDAQ:RTSX) announced that it has entered into definitive purchase agreements to acquire three radiation centers in New Jersey, which currently treat more than 60...

Successful pre-IND meeting for AVR118 with FDA reported.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that the company had a successful pre-investigational new drug (IND) meeting with the U.S. Food & Drug Administration (FDA) at the end of August. ...

Yeast-based immunotherapy causes mutation-selective tumor remission.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Ras-targeted, whole yeast-based immunotherapy resulted in mutation-selective tumor remission. "Activating mutations in Ras oncoproteins represent attractive targets for cancer immunotherapy, but...

Animal health company launches trials on dogs with heart diseases.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- In October 2004 Orion Pharma Animal Health will launch extensive clinical field studies on dogs with heart diseases. The aim of the project is to develop treatment for dogs with heart problems. ...

Par Pharmaceutical enters marketing agreement to its nitroglycerin lingual spray.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- NovaDel Pharma Inc. (AMEX:NVD) announced that is has entered into a licensing agreement with Par Pharmaceutical (NYSE:PRX) to market its nitroglycerin lingual spray. In June, NovaDel filed a new...

COPD patients prefer Respimat Soft MistTM Inhaler.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Respimat Soft MistTM Inhaler (SMI) represents a major step forward in inhalation therapy, resulting in high patient preference and satisfaction over other devices. The results of the analysis were...

New research targets management of COPD.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- New research into the management of chronic obstructive pulmonary disease (COPD), a debilitating respiratory illness, shows that patients treated with the inhaled drug Spiriva (tiotropium) experience...

Spiriva reduces COPD exacerbations, related health resource burden, data shows.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Spiriva (tiotropium) significantly reduced exacerbations and health resource utilization compared with placebo in patients with Chronic Obstructive Pulmonary Disease (COPD), according to data presented...

Study shows clinical trials last longer than expected.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Clinical trials last 42% longer than expected in phase I, 31% longer in phase II, and 30% beyond planned deadlines in phase III, according to a study recently conducted by Cutting Edge Information. ...

Companies to commence second phase III trial for milnacipran in Q4.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Cypress Bioscience, Inc., (CYPB) expects its partner, Forest Laboratories (FRX) to initiate the second phase III trial evaluating milnacipran for the treatment of fibromyalgia syndrome (FMS) during the...

Diversa gets milestone payments for identifying protein therapeutic candidates.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Diversa Corp. (DVSA) announced that the company has identified several lead protein therapeutic candidates under its research and product development agreement with Syngenta (SYT), resulting in...

Outline provided for developing national clinical trials registry.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- For the first time since announcing its support of a national clinical trials registry, the American Medical Association outlined to Congress key criteria needed to make such a registry effective. ...

CRO group establishes global influence with Input to EMEA.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- The Association of Clinical Research Organizations (ACRO), representing companies that are key participants in the clinical development of new medicinal products, is consulting regularly with European...

Alliance to discover, develop multiple small molecule oncology products.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., and Biogen Idec (BIIB) announced a collaboration to discover and develop small molecule cancer therapeutics targeting kinases, a family of cell signaling enzymes that play...

Financing agreement signed with HiProtech International.
October 4, 2004... 2004 OCT 4 - (NewsRx.com & NewsRx.net) -- Aquagen International, Inc., a manufacturer and distributor of premier oxygen supplement products, announced that it has signed an agreement with HiProtech International, Inc., an independent financing...